These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 15525731)
61. Drug patents. Universities, NIH hear the price isn't right on essential drugs. Marshall E Science; 2001 Apr; 292(5517):614-5. PubMed ID: 11330302 [No Abstract] [Full Text] [Related]
62. Scripps-Sandoz deal comes under fire. Anderson C Science; 1993 Feb; 259(5097):889. PubMed ID: 8438149 [No Abstract] [Full Text] [Related]
63. NerveCenter: Biomedical research funding a vital part of the economic stimulus plan. Lindsey H Ann Neurol; 2009 Feb; 65(2):A9-A11. PubMed ID: 19260032 [No Abstract] [Full Text] [Related]
66. National Institutes of Health. NIH aims to create 'homes' for clinical science. Kaiser J Science; 2005 Oct; 310(5747):422-3. PubMed ID: 16239450 [No Abstract] [Full Text] [Related]
67. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry. Dorfman HL; Reig LP Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876 [No Abstract] [Full Text] [Related]
68. Beyond government intervention: drug companies and bioethics. Dresser R Am J Bioeth; 2002; 2(3):42-3. PubMed ID: 12230855 [No Abstract] [Full Text] [Related]
69. Bioinformatics. Petition seeks public sharing of code. Malakoff D Science; 2001 Oct; 294(5540):27. PubMed ID: 11588225 [No Abstract] [Full Text] [Related]
70. The NIH stimulus--the recovery act and biomedical research. Steinbrook R N Engl J Med; 2009 Apr; 360(15):1479-81. PubMed ID: 19357402 [No Abstract] [Full Text] [Related]
71. Supporting the NIH before it is too late. Liang TJ Hepatology; 2006 Jul; 44(1):1-2. PubMed ID: 16799988 [No Abstract] [Full Text] [Related]
72. National Institutes of Health. Changes in peer review target young scientists, heavyweights. Kaiser J Science; 2008 Jun; 320(5882):1404. PubMed ID: 18556519 [No Abstract] [Full Text] [Related]
73. The future of research funding in academic medicine. Campbell EG N Engl J Med; 2009 Apr; 360(15):1482-3. PubMed ID: 19357403 [No Abstract] [Full Text] [Related]
74. Outlook: the profit problem in antibiotic R&D. Nathan C; Goldberg FM Nat Rev Drug Discov; 2005 Nov; 4(11):887-91. PubMed ID: 16247440 [TBL] [Abstract][Full Text] [Related]
75. U.S. science and austerity. Darwinism vs. social engineering at NIH. Kaiser J Science; 2011 Nov; 334(6057):753-4. PubMed ID: 22076357 [No Abstract] [Full Text] [Related]
76. The Bayh-Dole Act, a lion without claws. Feldman AM Clin Transl Sci; 2015 Feb; 8(1):3-4. PubMed ID: 25675969 [No Abstract] [Full Text] [Related]
77. Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry. Privitera M Epilepsy Res; 2006 Jan; 68(1):52-6. PubMed ID: 16377139 [TBL] [Abstract][Full Text] [Related]
78. Orphan drugs of the future? Service RF Science; 2004 Mar; 303(5665):1798. PubMed ID: 15031491 [No Abstract] [Full Text] [Related]